PATENT CLAIM ANALYSIS

Application Number: 16087918
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-10
Patent Classification: ["544", "280000"]

Abstract:
The present invention belongs to the field of pharmaceutical chemistry, and relates to a substituted pyrrolopyrimidine CDK inhibitor, in particular to a compound as shown in formula I or a pharmaceutically acceptable salt or solvate thereof, as well as a preparation method thereof and a pharmaceutical composition thereof. The present invention also relates to the use of the compound and the pharmaceutical composition thereof in the preparation of a drug for treating diseases associated with CDK inhibition. The compound according to the present invention has a marked inhibitory effect on CDK, excellent drug absorption and significantly superior oral absorption effect.

Claim (Index 13):
The compound or a pharmaceutically acceptable salt or solvate thereof according to  claim 12 , wherein the pharmaceutically acceptable salt is a hydrochloride salt.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.91071
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15566872', '13497067', '14158358', '13060154', '15546165']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7848660231860856
- 35 USC 102 Novelty (BERT): 0.5376327031136178
- Combined Prediction Score: 0.7601426911788388
- Mean Citation Score: 350.99347400000005
- Max Citation Score: 367.805
- Similarity Product: 242.6391521593929

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test